iData’s U.S. market report for dental bone graft substitutes and other biomaterials includes dental bone graft substitutes, dental growth factors, and dental barrier membranes. Dental bone graft substitutes (DBGS) represented the largest segment within the dental biomaterials market. Dental bone graft substitutes heavily rely on the dental implant market. There are corresponding trends between these markets which dictates the size and growth of the DBGS market. Through combining the DBGS and dental implant markets, we can discuss the impacts of COVID-19, the key market trends, and the procedures in which they are utilized.
WHAT ARE DENTAL BONE GRAFT SUBSTITUTES AND DENTAL IMPLANTS?
Dental bone graft substitutes (DBGS) pack the space left by missing bone and stimulate the growth of new bone. In addition to these functions, the use of DBGS has proven to be an efficient way to enhance bonding, healing, and longevity in traditional dental implants. The volume of DBGS used in a bone grafting procedure depends on the location and size of the bone needing repair.
On the other hand, dental implants are artificial tooth roots that support a missing tooth or teeth that prevent jawbone loss. These typically consist of a metal-based material, such as titanium. Usually, implants can be described based on their shape and method of attachment to the jaw.
WHAT IS THE U.S. MARKET GROWTH AND LARGEST MARKET SEGMENTS?
In 2020, the U.S. dental bone graft substitute and dental implant markets contracted due to the global COVID-19 pandemic. As a result, both markets dropped significantly in 2020. Regardless, recovery and growth into 2027 will occur as industry leaders are confident in their business fundamentals.
Allograft materials made up the largest segment in the U.S. DBGS market. This segment includes both mineralized and demineralized bone matrix allografts. In terms of growth, the DBGS market will continue to display slightly lower growth rates than the dental implant market. However, average selling prices (ASPs) for dental bone graft substitutes are decreasing into 2027 due to the introduction of newer, cost-effective entrants.
For dental implants, the U.S. market expects to recover faster than the rest of the dental market due to pent-up demand from the pandemic. Because of the increase in the aging population within the U.S., demand for dental implants is increasing. However, the emergence of attractively priced solutions has disrupted the market, with premium products losing market share to value and discount products.
WHICH PROCEDURES USE DENTAL BONE GRAFT SUBSTITUTES AND HOW MANY DO DENTAL PROFESSIONALS PERFORM PER YEAR?
Dental bone grafting procedures are typically in association with dental implants to restore the edentulous area of a missing tooth. Dental implants require sufficient bone tissue in the jawbone to support the implant and ensure proper integration into the mouth. If a patient has been toothless for a prolonged period, they run a high probability of having insufficient bone tissue. In these cases, patients would ideally require a bone graft to maximize the outcome of dental implant surgery.
Nearly all dental implant cases could potentially benefit from bone grafting; however, due to the additional time and expense, only about two-thirds of implant procedures include the use of bone grafting. In 2020, almost 1.5 million dental implants with bone graft substitutes occurred. Nevertheless, iData’s analysts expect an increase in all dental implant procedures by 2027.
MARKET RECAP AND FURTHER INSIGHTS
For more information on unit sales, average selling prices (ASPs), procedural volume, competitive analyses, and more, follow the link below to receive a free market synopsis for the U.S. dental bone graft substitutes market. Additionally, iData offers global, European, Latin American (Argentina, Mexico, Brazil), and Asia-Pacific (Australia, China, India, Japan, South Korea) DBGS reports.